IDiyas

For the Inventor, By the Inventor

Brussels, Belgium

Ucb Pharma, S.a.


USPTO Granted Patents = 179



Trademarks = 29

Forward Citations = 1,380

Loading Chart...
Loading Chart...

442 inventors (with patents filed for the assignee):

goldMedal Andrew George Popplewell (24 out of 35 patents)

silverMedal David Paul Humphreys (19 out of 45 patents)

bronzeMedal Daniel Christopher Brookings (14 out of 37 patents)

4.  Alastair David Griffiths Lawson (13 out of 37 patents)

5.  Ralph Adams (13 out of 39 patents)

6.  Mark Ellis (13 out of 15 patents)

7.  Benoît Kenda (11 out of 18 patents)

8.  Barry John Langham (11 out of 26 patents)

9.  Eric Freitag (10 out of 41 patents)

10.  Judi Charlotte Neuss (10 out of 17 patents)

11.  Darrell P Morgan (10 out of 19 patents)

12.  Dan Formosa (10 out of 11 patents)

13.  James Andrew Johnson (9 out of 21 patents)

14.  Alex Lee (9 out of 14 patents)

15.  Steven Vordenberg (9 out of 16 patents)


Core Competencies:
Bone Diseases
Sclerostin Antibodies
Protein Purification
Cognitive Function Enhancement
IL-6 Mediated Diseases
Antibody Molecules
Bacterial Host Strain
Dual Specificity Antibody Fusions
Therapeutically Active Compounds
Disulfide Stabilized Antibodies
Kinase Inhibitors
Medication Administration Devices

179 patents:

1. 11896667 - Treatment for bone diseases (2024-02-13),
2. 11851483 - Anti-sclerostin antibodies and their use to treat bone disorders as part of a regimen (2023-12-26),
3. 11702468 - Antibodies specific for sclerostin and methods for increasing bone mineralization (2023-07-18),
4. 11339214 - Protein purification (2022-05-24),
5. 10799583 - Treatment for bone diseases (2020-10-13),
6. 10189897 - Protein purification (2019-01-29),
7. 10017575 - Antibody molecules having specificity for human OX40 (2018-07-10),
8. 9957328 - Bacterial host strain expressing recombinant DSBC (2018-05-01),
9. 9925260 - Treatment for bone diseases (2018-03-27),
10. 9828438 - Dual specificity antibody fusions (2017-11-28),
11. 9791462 - Compositions and methods for increasing bone mineralization (2017-10-17),
12. 9751930 - Process for purifying proteins (2017-09-05),
13. 9725516 - Bacterial host strain expressing recombinant DSBC (2017-08-08),
14. 9657095 - Antibodies specific for sclerostin and methods for increasing bone mineralization (2017-05-23),
15. 9631015 - Methods for treating IL-6 mediated diseases with antibody molecules specific for IL-6 (2017-04-25),
UCB (Union Chimique Belge) is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative medicines and solutions for people living with neurological and immunological conditions. With a robust portfolio and a focus on patient-centric solutions, UCB aims to improve the lives of patients and contribute to the overall well-being of society. Through collaboration and innovation, UCB strives to make a meaningful impact in healthcare.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
179 Patents

#7 in Brussels

#24 in Belgium

#4,523 in the World

...
Brussels, Belgium

Ucb Pharma, S.a.

Forward Citations = 1,380

442 inventors:

goldMedal Andrew George Popplewell (24 out of 35 patents)

silverMedal David Paul Humphreys (19 out of 45 patents)

bronzeMedal Daniel Christopher Brookings (14 out of 37 patents)

4.  Alastair David Griffiths Lawson (13 out of 37 patents)

5.  Ralph Adams (13 out of 39 patents)

Please report any incorrect information to support@idiyas.com
Loading…